Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-07-27

Clinical Trial Update: The Effects of PG102, a Water Soluble Extract From Actinidia Arguta, on Serum Total IgE Levels [Phase 2]

View source ↗

Summary

Phase 2 trial assessing PG102, a water-soluble extract from Actinidia arguta, for its effect on serum total IgE levels in asymptomatic subjects with atopy and e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PG102 (PG102)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Asymptomatic Subjects With Atopy and Elevated Serum IgE | Phase 2 | Status: COMPLETED